Abnormal Return Analysis of Heatwave Announcement in China Has the Potential to Increase Indonesia's Coal Exports in Bumi and Adro Stocks
Jurnal Ekonomi LLDIKTI Wilayah 1 (JUKET) · 2023
DOI: 10.54076/juket.v3i1.263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Ekonomi LLDIKTI Wilayah 1 (JUKET), 2023. Verfasst von Lea Fathra Azha Nabiela und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study aims to determine the heatwave announcement in China can increase Indonesia's coal export potential. On the abnormal Return on shares of PT Bumi Resource Tbk (BUMI) and PT Adaro Energy Indonesia Tbk (ADRO). The method used to analyze this research is an event study. Hypothesis testing was carried out using normality tests, paired sample t-tests and one-sample T-tests. From the results of this study, it was found that there was no significant abnormal difference in return after the announcement was published. Therefore, the results were obtained that the published announcement did not contain information for investors because there was no abnormal return around the event.
Zitieren
APA
Nabiela, L. F. A., Nada, L., & Darmawan, D. (2023). Abnormal Return Analysis of Heatwave Announcement in China Has the Potential to Increase Indonesia's Coal Exports in Bumi and Adro Stocks. Jurnal Ekonomi LLDIKTI Wilayah 1 (JUKET). https://doi.org/10.54076/juket.v3i1.263
Vancouver
Nabiela LFA, Nada L, Darmawan D. Abnormal Return Analysis of Heatwave Announcement in China Has the Potential to Increase Indonesia's Coal Exports in Bumi and Adro Stocks. Jurnal Ekonomi LLDIKTI Wilayah 1 (JUKET). 2023. doi:10.54076/juket.v3i1.263
BibTeX
@article{Nabiela2023,
author = {Nabiela, Lea Fathra Azha and Nada, Lifatin and Darmawan, Darmawan},
title = {Abnormal Return Analysis of Heatwave Announcement in China Has the Potential to Increase Indonesia's Coal Exports in Bumi and Adro Stocks},
journal = {Jurnal Ekonomi LLDIKTI Wilayah 1 (JUKET)},
year = {2023},
doi = {10.54076/juket.v3i1.263}
}
EUVIMED